BridgeBio Pharma is back in focus after its fair value estimate was lifted from $89.79 to $100.05, an increase of about 11% that resets the conversation around upside and risk. That move aligns with ...
Looking for the best shoes for spring? Podiatrists weigh in on top sneakers, sandals, and flip-flops for plantar fasciitis, flat feet, and more – tested by real people.